A 28-year-old man from rural Maharashtra presents with a 6-month history of progressive back pain and low-grade fever. On examination, he has kyphotic deformity of the thoracic spine and a palpable paravertebral abscess. Plain radiographs show anterior vertebral body collapse at T5–T6 with disc space involvement. MRI reveals T2-weighted hyperintensity in the vertebral bodies and epidural extension. Sputum smear microscopy is negative for acid-fast bacilli, but GeneXpert MTB/RIF is positive. What is the most appropriate next step in management?

Explanation

## Management Strategy for Pott Disease **Key Point:** The standard of care for Pott disease is medical management with anti-tuberculous therapy (ATT) as the first-line treatment. Surgery is reserved for specific indications and is NOT routine. ### Medical Management Protocol The WHO and Indian guidelines recommend: 1. **Intensive phase:** RIPE (Rifampicin, Isoniazid, Pyrazinamide, Ethambutol) for **2 months** 2. **Continuation phase:** INH + RIF for **4 months** 3. **Total duration:** 6 months **High-Yield:** This 2+4 regimen (total 6 months) is the standard for drug-susceptible TB spine, NOT 6+4 months. ### Indications for Surgical Intervention Surgery is considered in the following scenarios: - **Active neurological deficit** (paraplegia, radiculopathy) unresponsive to medical therapy - **Severe kyphotic deformity** (>60°) with potential for late-onset paraplegia - **Spinal instability** (severe anterior column collapse with posterior ligament disruption) - **Non-compliance** or drug-resistant TB - **Failure to respond** to ATT after 3–6 months **Clinical Pearl:** In this case, the patient has epidural extension but NO mention of active neurological deficit. Therefore, medical management is appropriate as the initial approach, with surgery reserved for deterioration. ### Why NOT Immediate Surgery? Early surgery in uncomplicated Pott disease: - Does not improve outcomes compared to ATT alone [cite:Robbins 10e Ch 8] - Increases morbidity and cost - Is reserved for complications, not routine management ### Role of Corticosteroids Corticosteroids are NOT routinely recommended in Pott disease and do not prevent kyphotic progression. They may be considered in severe spinal cord compression with neurological deficit, but evidence is limited. ## Summary Table: Management Approach | Scenario | Management | | --- | --- | | Uncomplicated Pott disease (no neurological deficit) | ATT alone (2+4 months) | | Pott disease + active paraplegia | ATT + early surgical decompression | | Pott disease + severe kyphosis (>60°) | ATT + planned surgery for stabilization | | Drug-resistant TB spine | ATT (longer duration) ± surgery | **High-Yield:** GeneXpert MTB/RIF positivity confirms TB and also detects rifampicin resistance, guiding drug selection—this patient is susceptible, so standard RIPE is appropriate.